AnGioTherapeutics

La société est consacrée au développement d'une nouvelle classe de biomédicament: les anti-angiogéniques de deuxième génération

  • Stage Concept Only
  • Industry Biotechnology
  • Location Fontenay-aux-Roses, IDF, France
  • Currency USD
  • Founded September 2014
  • Employees 0

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free